Omeros Corporation Garners $68,200,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=934d0355-a89c-4e77-a6ec-ef46236cda69&Preview=1 -
Date
10/8/2009 -
Company Name
Omeros Corporation -
Mailing Address
1420 Fifth Avenue Seattle, WA 98101 -
Company Description
Omeros recognized that a combination of agents acting on multiple molecular targets may be required for optimal therapeutic effect. Omeros’ product candidates are designed to modulate the molecular mechanisms of pathologic conditions rather than just treating their symptoms. -
Website
http://www.omeros.com -
Transaction Type
IPO -
Transaction Amount
$68,200,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes from the IPO are on file with the company statements at the SEC. -
M&A Terms
